Trial Profile
A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Mar 2018
Price :
$35
*
At a glance
- Drugs Perifosine (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AEterna Zentaris Inc; AOI Pharmaceuticals; Keryx Biopharmaceuticals
- 12 Mar 2018 Status changed from active, no longer recruiting to completed.
- 18 May 2012 Additional lead trial centre (AEterna Zentaris Inc) added as reported by ClinicalTrials.gov.
- 01 May 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.